針市場：タイプ別（従来型（ベベル、ベント）＆安全）、製品別（縫合、採血、吸入）、素材別（ステンレス、プラスチック）、デリバリーモード別（点滴、注射、皮下注射）、エンドユーザー別（病院、診断センター）-2027年までの世界予測

Needles Market by Type (Conventional (Bevel, Vented) & Safety), Product (Suture, Blood Collection, Insufflation), Material (Stainless Steel, Plastic), Delivery Mode (IV, IM, Hypodermic), End-User (Hospitals, Diagnostic Centres) - Global Forecast to 2027

針の世界市場規模は、2022年の77億ドルから2027年には106億ドルに達し、予測期間中のCAGRは6.7%と予測されています。市場を牽引しているのは、事故や外傷の発生率の増加、新興市場における病院数の増加といった要... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2022年11月9日	US$4,950 シングルユーザライセンスライセンス・価格情報・注文方法はこちら	221	249	英語

サマリー

針の世界市場規模は、2022年の77億ドルから2027年には106億ドルに達し、予測期間中のCAGRは6.7%と予測されています。市場を牽引しているのは、事故や外傷の発生率の増加、新興市場における病院数の増加といった要因です。一方、吸引針や生検針の使用に伴う感染症のリスクは、今後数年間、市場の成長をある程度制限すると予想されます。

"コンベンショナルニードル市場では、予測期間中、ベベルニードルが最大の市場シェアを占めた"
コンベンショナルニードル市場は、ベベルニードル、ブラントフィルニードル、ベントニードル、フィルターニードルに区分されます。2021年、ベベルニードルがかなりの市場シェアを占めたのは、市場プレイヤーの多くが、いくつかの歯科用途のベベル技術によるニードルの開発に注力しているためである。

"アクティブニードルセグメントが最大の市場シェアを占めた"
タイプに基づいて、安全針市場は、アクティブ針とパッシブ針に区分されます。アクティブニードルセグメントは、その利点のために2021年に最大の市場シェアを占めた。これらの針は、組織の界面を介してより良い浸透を提供し、痛みや組織の外傷を減らすのに役立つためである。さらに、深い場所での先端のたわみを軽減し、困難な角度での先端の視認性を高めることもできます。

"APAC地域が最も高いCAGRを占めた"
世界の針市場は、4つの地域に分けられます。北米、アジア太平洋地域、欧州、その他の地域です。地域別分析によると、アジア太平洋地域は2021年および将来にわたって大きな市場シェアを維持する可能性が高い。アジア太平洋地域は、高齢者人口の増加、医療費の増加、交通事故の増加によって推進されています。一方、北米は、慢性疾患の発生率の増加により、今後数年間で大きな成長を遂げるでしょう。心血管疾患の有病率の増加、外科手術の増加。

本レポートのために実施した主なインタビューは、以下のように分類されます。

- 企業タイプ別ティア1：32％、ティア2：44％、ティア3：24％。
- 役職別Cレベル：30％、Dレベル：34％、その他：36
- 地域別地域別：北米40％、欧州28％、アジア太平洋20％、その他の地域12
報告書に掲載された企業一覧
メドトロニック（アイルランド）。
ベクトン・ディッキンソン・アンド・カンパニー（米国）。
B.Braun Melsungen AG（ドイツ）。
Stryker Corporation（米国）。
エシコン社（ジョンソン・アンド・ジョンソン社子会社）（米国）。
ボストン・サイエンティフィック・コーポレーション（米国）。
テルモ株式会社（日本）。
オリンパス・コーポレーション（米国）。
メリットメディカル（米国）。
グライナーホールディングAG（オーストリア）。
Merck KgA（ドイツ）。
ハミルトン社（米国）ユニメドSA,
アルゴン・メディカル・デバイス・インク（米国）。
ニプロ株式会社（日本）。
スミスメディカル(米)
アルティメッド・インク（米国）。
八光株式会社(日本）。
クレガナ（アイルランド）。
DTRメディカル（イギリス）。
ロケットメディカル(英国)

研究対象

本レポートでは、製品、タイプ、デリバリーモード、材料、用途、エンドユーザー、地域などに基づいてニードル市場を調査しています。また、市場成長に影響を与える要因（促進要因、阻害要因、機会、課題など）を分析しています。ステークホルダーに対しては市場の機会と課題を評価し、市場リーダーに対しては競争環境の詳細を提供します。また、マイクロマーケットについては、その成長動向、展望、ニードル市場全体への貢献度に関して調査しています。本レポートでは、4つの主要地域に関して、市場セグメントの収益を予測しています。

レポート購入の理由
本レポートは、以下のポインタに関する洞察を提供しています。

市場の浸透。市場浸透：市場上位25社が提供する針に関する包括的な情報。製品、タイプ、デリバリーモード、材料、アプリケーション、エンドユーザー、地域別にニードル市場を分析しています。
市場開拓。有利な新興市場に関する包括的な情報を提供します。本レポートでは、主要な地域ごとの各種固定装置市場を分析しています。
市場の多様化。針市場における未開拓の地域、最近の開発、投資に関する徹底的な情報。
競合の評価。注射針市場における主要企業の市場シェアと戦略に関する詳細な評価
市場の位置づけ。利害関係者が競争環境をより良く理解し、より良いビジネスの位置付けと適切な市場参入戦略を立てるためのより多くの洞察を得ることができます。

ページTOPに戻る

1 INTRODUCTION 20
1.1 STUDY OBJECTIVES 20
1.2 MARKET DEFINITION 20
1.2.1 INCLUSIONS AND EXCLUSIONS 20
1.3 MARKET SCOPE 21
1.3.1 GEOGRAPHIC SCOPE 21
1.3.2 YEARS CONSIDERED 22
1.4 CURRENCY CONSIDERED 22
1.5 LIMITATIONS 22
1.6 MARKET STAKEHOLDERS 23
1.7 SUMMARY OF CHANGES 23
2 RESEARCH METHODOLOGY 24
2.1 RESEARCH DATA 24
FIGURE 1 RESEARCH DESIGN 24
2.1.1 SECONDARY DATA 25
2.1.1.1 Secondary sources 26
2.1.2 PRIMARY DATA 26
FIGURE 2 PRIMARY SOURCES 26
2.1.2.1 Key data from primary sources 27
2.1.2.2 Key industry insights 28
2.1.2.3 Breakdown of primary interviews 29
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS 29
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS 29
2.2 MARKET SIZE ESTIMATION 29
FIGURE 5 REVENUE SHARE ANALYSIS 30
2.2.1 GROWTH FORECAST 31
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 31
FIGURE 7 TOP-DOWN APPROACH 32
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 33
FIGURE 8 DATA TRIANGULATION METHODOLOGY 33
2.4 MARKET SHARE ANALYSIS 34
2.5 ASSUMPTIONS FOR STUDY 34
2.6 INDICATORS AND ASSUMPTIONS 35
2.7 RISK ASSESSMENT 35
TABLE 1 RISK ASSESSMENT 35
3 EXECUTIVE SUMMARY 36
FIGURE 9 NEEDLES MARKET, BY PRODUCT, 2022 VS. 2027 (USD BILLION) 36
FIGURE 10 NEEDLES MARKET, BY TYPE, 2022 VS. 2027 (USD BILLION) 37
FIGURE 11 NEEDLES MARKET, BY DELIVERY MODE, 2022 VS. 2027 (USD BILLION) 37
FIGURE 12 NEEDLES MARKET, BY APPLICATION, 2022 VS. 2027 (USD BILLION) 38
FIGURE 13 NEEDLES MARKET, BY END USER, 2022 VS. 2027 (USD BILLION) 38
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF NEEDLES MARKET 39
4 PREMIUM INSIGHTS 40
4.1 NEEDLES MARKET OVERVIEW 40
FIGURE 15 RISING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET 40
4.2 NORTH AMERICA: NEEDLES MARKET, BY TYPE AND COUNTRY (2022) 41
FIGURE 16 CONVENTIONAL NEEDLES TO ACCOUNT FOR LARGEST MARKET SHARE IN 2022 41
4.3 NEEDLES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 41
FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 41
5 MARKET OVERVIEW 42
5.1 INTRODUCTION 42
5.2 MARKET DYNAMICS 42
FIGURE 18 NEEDLES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 42
5.2.1 DRIVERS 43
5.2.1.1 High prevalence of chronic diseases 43
FIGURE 19 US: NUMBER OF PEOPLE WITH CHRONIC CONDITIONS, 1995–2030 (MILLION) 43
FIGURE 20 INCIDENCES OF DIABETES, 2021 VS. 2025 (MILLION) 44
5.2.1.2 Growing geriatric population 44
5.2.1.3 Rising number of accidents and trauma cases 45
5.2.1.4 Increasing number of hospitals in emerging markets 45
5.2.1.5 Increasing preference for minimally invasive biopsies 45
5.2.1.6 Increasing demand for vaccines 46
5.2.2 RESTRAINTS 46
5.2.2.1 Rising incidence of needlestick injuries and infections 46
5.2.2.2 Risk of infections associated with use of aspiration and biopsy needles 47
5.2.3 OPPORTUNITIES 47
5.2.3.1 Expanding injectables market 47
5.2.3.2 Rise in self-administration of drugs 48
5.2.3.3 Rising use of safety needles 48
5.2.3.4 Emerging markets 48

5.2.4 CHALLENGES 49
5.2.4.1 Use of needle-free injection technology 49
5.2.4.2 Growing focus on development of alternative drug delivery methods 49
5.3 VALUE CHAIN ANALYSIS 49
FIGURE 21 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES 50
5.4 SUPPLY CHAIN ANALYSIS 50
FIGURE 22 DIRECT DISTRIBUTION—PREFERRED STRATEGY FOR PROMINENT COMPANIES 51
5.5 PORTER’S FIVE FORCES ANALYSIS 51
5.5.1 THREAT OF NEW ENTRANTS 51
5.5.2 INTENSITY OF COMPETITIVE RIVALRY 52
5.5.3 BARGAINING POWER OF BUYERS 52
5.5.4 BARGAINING POWER OF SUPPLIERS 52
5.5.5 THREAT OF SUBSTITUTES 52
5.6 KEY STAKEHOLDERS AND BUYING CRITERIA 52
5.6.1 KEY STAKEHOLDERS IN BUYING PROCESS 52
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS 52
TABLE 2 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS (%) 53
5.6.2 BUYING CRITERIA 53
FIGURE 24 KEY BUYING CRITERIA FOR TOP THREE END USERS 53
TABLE 3 KEY BUYING CRITERIA FOR TOP THREE END USERS 53
5.7 REGULATORY LANDSCAPE 54
5.7.1 NORTH AMERICA 54
5.7.1.1 US 54
5.7.1.2 Canada 54
TABLE 4 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 54
5.7.2 EUROPE 55
5.7.3 ASIA PACIFIC 55
5.7.3.1 Japan 55
TABLE 5 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 56
5.7.3.2 China 56
TABLE 6 CHINA: CLASSIFICATION OF MEDICAL DEVICES 56
5.7.3.3 India 57
5.8 TRADE ANALYSIS 58
TABLE 7 IMPORT DATA FOR HS CODE 901839, BY COUNTRY, 2017–2021 (USD MILLION) 58
TABLE 8 EXPORT DATA FOR HS CODE 901839, BY COUNTRY, 2017–2021 (USD MILLION) 58

5.9 ECOSYSTEM ANALYSIS 59
TABLE 9 ROLE IN ECOSYSTEM 59
FIGURE 25 KEY PLAYERS OPERATING IN NEEDLES MARKET 60
5.10 PATENT ANALYSIS 60
5.11 KEY CONFERENCES AND EVENTS IN 2022–2023 61
TABLE 10 LIST OF CONFERENCES AND EVENTS, 2022–2023 61
5.12 PRICING ANALYSIS 62
5.12.1 AVERAGE SELLING PRICE OF PRODUCTS, BY KEY PLAYER 62
TABLE 11 PRICE RANGE OF KEY PRODUCTS IN NEEDLES MARKET (USD) 62
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 62
5.14 TECHNOLOGY ANALYSIS 63
6 NEEDLES MARKET, BY PRODUCT 64
6.1 INTRODUCTION 65
TABLE 12 NEEDLES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 65
6.2 BLOOD COLLECTION NEEDLES 65
6.2.1 INCREASING NUMBER OF BLOOD COLLECTION PROCEDURES TO DRIVE MARKET 65
TABLE 13 EXAMPLES OF BLOOD COLLECTION NEEDLES 66
TABLE 14 BLOOD COLLECTION NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION) 66
6.3 PEN NEEDLES 66
TABLE 15 EXAMPLES OF PEN NEEDLES 67
TABLE 16 PEN NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 67
TABLE 17 PEN NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION) 68
6.3.1 STANDARD NEEDLES 68
6.3.1.1 Standard pen needles preferred over safety pen needles as they are more affordable 68
TABLE 18 STANDARD PEN NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION) 68
6.3.2 SAFETY NEEDLES 69
6.3.2.1 Growing concerns over needlestick injuries to drive growth 69
TABLE 19 SAFETY PEN NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION) 69
6.4 SUTURE NEEDLES 70
6.4.1 INCREASING NUMBER OF SURGICAL PROCEDURES TO DRIVE MARKET 70
TABLE 20 EXAMPLES OF SUTURE NEEDLES 70
TABLE 21 SUTURE NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION) 70
6.5 OPHTHALMIC NEEDLES 71
6.5.1 GROWING NUMBER OF BLOOD COLLECTION PROCEDURES TO DRIVE MARKET 71
TABLE 22 EXAMPLES OF OPHTHALMIC NEEDLES 71
TABLE 23 OPHTHALMIC NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION) 72

6.6 DENTAL NEEDLES 72
6.6.1 MOST COMMONLY MADE OF STAINLESS STEEL 72
TABLE 24 EXAMPLES OF DENTAL NEEDLES 72
TABLE 25 DENTAL NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION) 73
6.7 INSUFFLATION NEEDLES 73
6.7.1 GROWING NUMBER OF MINIMALLY INVASIVE PROCEDURES TO BOOST MARKET GROWTH 73
TABLE 26 EXAMPLES OF INSUFFLATION NEEDLES 73
TABLE 27 INSUFFLATION NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION) 74
6.8 ASPIRATION AND BIOPSY NEEDLES 74
TABLE 28 EXAMPLES OF ASPIRATION AND BIOPSY NEEDLES 74
TABLE 29 ASPIRATION AND BIOPSY NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 75
TABLE 30 ASPIRATION AND BIOPSY NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION) 75
6.8.1 BIOPSY NEEDLES 76
TABLE 31 BIOPSY NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 76
TABLE 32 BIOPSY NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION) 76
6.8.1.1 Core biopsy needles 77
6.8.1.1.1 Widely used for sample collection in most prevalent cancer types 77
TABLE 33 CORE BIOPSY NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION) 77
6.8.1.2 Vacuum-assisted biopsy needles 78
6.8.1.2.1 High-volume sampling and greater specificity of VAB procedures to drive growth 78
TABLE 34 VACUUM-ASSISTED BIOPSY NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION) 78
6.8.2 ASPIRATION NEEDLES 79
6.8.2.1 Cost-effectiveness of needles to support market growth 79
TABLE 35 ASPIRATION NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION) 79
6.9 OTHER NEEDLES 80
TABLE 36 OTHER NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION) 80
7 NEEDLES MARKET, BY DELIVERY MODE 81
7.1 INTRODUCTION 82
TABLE 37 NEEDLES MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 82
7.2 HYPODERMIC NEEDLES 82
7.2.1 FASTEST-GROWING DELIVERY MODE SEGMENT 82
TABLE 38 HYPODERMIC NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION) 83
7.3 INTRAVENOUS NEEDLES 83
7.3.1 INCREASING DEMAND FOR VACCINES TO BOOST MARKET GROWTH 83
TABLE 39 INTRAVENOUS NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION) 84
7.4 INTRAMUSCULAR NEEDLES 84
7.4.1 INCREASING PREVALENCE OF CHRONIC DISEASES TO SUPPORT MARKET GROWTH 84
TABLE 40 INTRAMUSCULAR NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION) 84
7.5 INTRAPERITONEAL NEEDLES 85
7.5.1 RISING NUMBER OF OVARIAN CANCER CASES TO DRIVE ADOPTION OF INTRAPERITONEAL NEEDLES 85
TABLE 41 INTRAPERITONEAL NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION) 85
8 NEEDLES MARKET, BY TYPE 86
8.1 INTRODUCTION 87
TABLE 42 NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 87
8.2 CONVENTIONAL NEEDLES 87
TABLE 43 CONVENTIONAL NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 44 CONVENTIONAL NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION) 88
8.2.1 BEVEL NEEDLES 88
8.2.1.1 Bevel needles to dominate market in 2022 88
TABLE 45 BEVEL NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION) 89
8.2.2 BLUNT FILL NEEDLES 89
8.2.2.1 Increasing prevalence of needlestick injuries to drive market 89
TABLE 46 BLUNT FILL NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION) 89
8.2.3 VENTED NEEDLES 90
8.2.3.1 Increasing focus on vaccination to boost market growth 90
TABLE 47 VENTED NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION) 90
8.2.4 FILTER NEEDLES 90
8.2.4.1 Increasing usage for medication administration 90
TABLE 48 FILTER NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION) 91
8.3 SAFETY NEEDLES 91
TABLE 49 SAFETY NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 91
TABLE 50 SAFETY NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION) 92
8.3.1 ACTIVE NEEDLES 92
8.3.1.1 Largest and fastest-growing segment of safety needles market 92
TABLE 51 ACTIVE NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION) 92
8.3.2 PASSIVE NEEDLES 93
8.3.2.1 Increasing prevalence of chronic diseases to drive market growth 93
TABLE 52 PASSIVE NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION) 93
9 NEEDLES MARKET, BY MATERIAL 94
9.1 INTRODUCTION 95
TABLE 53 NEEDLES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 95
9.2 STAINLESS STEEL/METALLIC NEEDLES 95
9.2.1 WIDESPREAD USE IN MEDICAL AND RESEARCH APPLICATIONS 95
TABLE 54 EXAMPLES OF STAINLESS STEEL/METALLIC NEEDLES 96
TABLE 55 STAINLESS STEEL/METALLIC NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION) 96
9.3 GLASS NEEDLES 96
9.3.1 INCREASED APPLICATION IN DRUG DELIVERY TO DRIVE GROWTH 96
TABLE 56 GLASS NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION) 97
9.4 PLASTIC NEEDLES 98
9.4.1 ISSUES ASSOCIATED WITH GLASS NEEDLES TO DRIVE ADOPTION OF PLASTIC NEEDLES 98
TABLE 57 PLASTIC NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION) 98
9.5 POLYETHERETHERKETONE (PEEK) NEEDLES 99
9.5.1 APPLICATION OF PEEK NEEDLES IN WIDE RANGE OF SURGERIES AND PROCEDURES TO DRIVE GROWTH 99
TABLE 58 EXAMPLES OF PEEK NEEDLES 99
TABLE 59 PEEK NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION) 99
10 NEEDLES MARKET, BY APPLICATION 100
10.1 INTRODUCTION 101
TABLE 60 NEEDLES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 101
10.2 DIAGNOSTICS 101
10.2.1 LARGEST AND FASTEST-GROWING APPLICATION SEGMENT 101
TABLE 61 NEEDLES MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 101
10.3 THERAPEUTICS 102
10.3.1 RISING PREVALENCE OF DISEASES TO DRIVE MARKET 102
TABLE 62 NEEDLES MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 102
11 NEEDLES MARKET, BY END USER 103
11.1 INTRODUCTION 104
TABLE 63 NEEDLES MARKET, BY END USER, 2020–2027 (USD MILLION) 104
11.2 HOSPITALS 104
11.2.1 HIGH VOLUME OF BLOOD TRANSFUSIONS CONDUCTED IN HOSPITALS TO SUPPORT MARKET GROWTH 104
TABLE 64 NEEDLES MARKET FOR HOSPITALS, BY REGION, 2020–2027 (USD MILLION) 105
11.3 DIAGNOSTIC CENTERS 106
11.3.1 INCREASING NUMBER OF DIAGNOSTIC TESTS TO DRIVE ADOPTION OF NEEDLES 106
TABLE 65 NEEDLES MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2020–2027 (USD MILLION) 106
11.4 HOME HEALTHCARE 107
11.4.1 INCREASING USE OF INJECTIONS IN HOME CARE FOR MANAGEMENT OF CHRONIC DISEASES TO DRIVE MARKET 107
TABLE 66 NEEDLES MARKET FOR HOME HEALTHCARE, BY REGION, 2020–2027 (USD MILLION) 107
11.5 OTHER END USERS 108
TABLE 67 NEEDLES MARKET FOR OTHER END USERS, BY REGION, 2020–2027 (USD MILLION) 108
12 NEEDLES MARKET, BY REGION 109
12.1 INTRODUCTION 110
TABLE 68 NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION) 110
12.2 NORTH AMERICA 110
FIGURE 26 NORTH AMERICA: NEEDLES MARKET SNAPSHOT 111
TABLE 69 NORTH AMERICA: NEEDLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 111
TABLE 70 NORTH AMERICA: NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 71 NORTH AMERICA: CONVENTIONAL NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 72 NORTH AMERICA: SAFETY NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 73 NORTH AMERICA: NEEDLES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 113
TABLE 74 NORTH AMERICA: PEN NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 113
TABLE 75 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 113
TABLE 76 NORTH AMERICA: BIOPSY NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 77 NORTH AMERICA: NEEDLES MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 114
TABLE 78 NORTH AMERICA: NEEDLES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 114
TABLE 79 NORTH AMERICA: NEEDLES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 115
TABLE 80 NORTH AMERICA: NEEDLES MARKET, BY END USER, 2020–2027 (USD MILLION) 115
12.2.1 US 115
12.2.1.1 US dominates North American needles market 115
TABLE 81 US: NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 116
TABLE 82 US: NEEDLES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 117
TABLE 83 US: NEEDLES MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 117
TABLE 84 US: NEEDLES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 118
TABLE 85 US: NEEDLES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 118
TABLE 86 US: NEEDLES MARKET, BY END USER, 2020–2027 (USD MILLION) 118
12.2.2 CANADA 119
12.2.2.1 High prevalence of diseases in Canada to support market growth 119
TABLE 87 CANADA: NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 119
TABLE 88 CANADA: NEEDLES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 120
TABLE 89 CANADA: NEEDLES MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 120
TABLE 90 CANADA: NEEDLES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 121
TABLE 91 CANADA: NEEDLES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 92 CANADA: NEEDLES MARKET, BY END USER, 2020–2027 (USD MILLION) 121
12.3 EUROPE 122
TABLE 93 EUROPE: NEEDLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 122
TABLE 94 EUROPE: NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 122
TABLE 95 EUROPE: CONVENTIONAL NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 123
TABLE 96 EUROPE: SAFETY NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 123
TABLE 97 EUROPE: NEEDLES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 123
TABLE 98 EUROPE: PEN NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 124
TABLE 99 EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 124
TABLE 100 EUROPE: BIOPSY NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 124
TABLE 101 EUROPE: NEEDLES MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 125
TABLE 102 EUROPE: NEEDLES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 125
TABLE 103 EUROPE: NEEDLES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 125
TABLE 104 EUROPE: NEEDLES MARKET, BY END USER, 2020–2027 (USD MILLION) 126
12.3.1 GERMANY 126
12.3.1.1 Largest and fastest-growing market for needles in Europe 126
TABLE 105 GERMANY: NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 126
TABLE 106 GERMANY: NEEDLES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 127
TABLE 107 GERMANY: NEEDLES MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 127
TABLE 108 GERMANY: NEEDLES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 128
TABLE 109 GERMANY: NEEDLES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 110 GERMANY: NEEDLES MARKET, BY END USER, 2020–2027 (USD MILLION) 128
12.3.2 FRANCE 129
12.3.2.1 Rising need for blood components to support market growth 129
TABLE 111 FRANCE: NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 129
TABLE 112 FRANCE: NEEDLES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 129
TABLE 113 FRANCE: NEEDLES MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 130
TABLE 114 FRANCE: NEEDLES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 130
TABLE 115 FRANCE: NEEDLES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 130
TABLE 116 FRANCE: NEEDLES MARKET, BY END USER, 2020–2027 (USD MILLION) 131
12.3.3 UK 131
12.3.3.1 Increasing incidence of cancer to drive market growth 131
TABLE 117 UK: NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 118 UK: NEEDLES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 132
TABLE 119 UK: NEEDLES MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 133
TABLE 120 UK: NEEDLES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 133
TABLE 121 UK: NEEDLES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 133
TABLE 122 UK: NEEDLES MARKET, BY END USER, 2020–2027 (USD MILLION) 134
12.3.4 SPAIN 134
12.3.4.1 Growing road accidents to drive market 134
TABLE 123 SPAIN: NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 135
TABLE 124 SPAIN: NEEDLES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 135
TABLE 125 SPAIN: NEEDLES MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 136
TABLE 126 SPAIN: NEEDLES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 136
TABLE 127 SPAIN: NEEDLES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 136
TABLE 128 SPAIN: NEEDLES MARKET, BY END USER, 2020–2027 (USD MILLION) 137
12.3.5 ITALY 137
12.3.5.1 Increasing number of blood donations to drive adoption of needles 137
TABLE 129 ITALY: NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 137
TABLE 130 ITALY: NEEDLES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 138
TABLE 131 ITALY: NEEDLES MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 138
TABLE 132 ITALY: NEEDLES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 139
TABLE 133 ITALY: NEEDLES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 134 ITALY: NEEDLES MARKET, BY END USER, 2020–2027 (USD MILLION) 139
12.3.6 REST OF EUROPE 140
TABLE 135 REST OF EUROPE: NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 140
TABLE 136 REST OF EUROPE: NEEDLES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 141
TABLE 137 REST OF EUROPE: NEEDLES MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 141
TABLE 138 REST OF EUROPE: NEEDLES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 142
TABLE 139 REST OF EUROPE: NEEDLES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 140 REST OF EUROPE: NEEDLES MARKET, BY END USER, 2020–2027 (USD MILLION) 142
12.4 ASIA PACIFIC 143
FIGURE 27 ASIA PACIFIC: NEEDLES MARKET SNAPSHOT 143
TABLE 141 ASIA PACIFIC: NEEDLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 144
TABLE 142 ASIA PACIFIC: NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 144
TABLE 143 ASIA PACIFIC: CONVENTIONAL NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 144
TABLE 144 ASIA PACIFIC: SAFETY NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 145
TABLE 145 ASIA PACIFIC: NEEDLES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 145
TABLE 146 ASIA PACIFIC: PEN NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 145
TABLE 147 ASIA PACIFIC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 148 ASIA PACIFIC: BIOPSY NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 149 ASIA PACIFIC: NEEDLES MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 146
TABLE 150 ASIA PACIFIC: NEEDLES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 147
TABLE 151 ASIA PACIFIC: NEEDLES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 147
TABLE 152 ASIA PACIFIC: NEEDLES MARKET, BY END USER, 2020–2027 (USD MILLION) 147
12.4.1 CHINA 148
12.4.1.1 Increasing number of surgical procedures to drive market 148
TABLE 153 CHINA: NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 148
TABLE 154 CHINA: NEEDLES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 149
TABLE 155 CHINA: NEEDLES MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 149
TABLE 156 CHINA: NEEDLES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 150
TABLE 157 CHINA: NEEDLES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 158 CHINA: NEEDLES MARKET, BY END USER, 2020–2027 (USD MILLION) 150
12.4.2 JAPAN 151
12.4.2.1 Rising geriatric population to drive market 151
TABLE 159 JAPAN: NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 160 JAPAN: NEEDLES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 152
TABLE 161 JAPAN: NEEDLES MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 152
TABLE 162 JAPAN: NEEDLES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 153
TABLE 163 JAPAN: NEEDLES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 153
TABLE 164 JAPAN: NEEDLES MARKET, BY END USER, 2020–2027 (USD MILLION) 153
12.4.3 INDIA 154
12.4.3.1 Rising demand for innovative technologies to support market growth 154
TABLE 165 INDIA: NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 154
TABLE 166 INDIA: NEEDLES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 154
TABLE 167 INDIA: NEEDLES MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 155
TABLE 168 INDIA: NEEDLES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 155
TABLE 169 INDIA: NEEDLES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 155
TABLE 170 INDIA: NEEDLES MARKET, BY END USER, 2020–2027 (USD MILLION) 156
12.4.4 REST OF ASIA PACIFIC 156
TABLE 171 REST OF ASIA PACIFIC: NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 156
TABLE 172 REST OF ASIA PACIFIC: NEEDLES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 157
TABLE 173 REST OF ASIA PACIFIC: NEEDLES MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 157
TABLE 174 REST OF ASIA PACIFIC: NEEDLES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 158
TABLE 175 REST OF ASIA PACIFIC: NEEDLES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 176 REST OF ASIA PACIFIC: NEEDLES MARKET, BY END USER, 2020–2027 (USD MILLION) 158
12.5 REST OF THE WORLD 159
TABLE 177 REST OF THE WORLD: NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 178 REST OF THE WORLD: CONVENTIONAL NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 179 REST OF THE WORLD: SAFETY NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 160
TABLE 180 REST OF THE WORLD: NEEDLES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 160
TABLE 181 REST OF THE WORLD: PEN NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 160
TABLE 182 REST OF THE WORLD: ASPIRATION AND BIOPSY NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 161
TABLE 183 REST OF THE WORLD: BIOPSY NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 161
TABLE 184 REST OF THE WORLD: NEEDLES MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 161
TABLE 185 REST OF THE WORLD: NEEDLES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 162
TABLE 186 REST OF THE WORLD: NEEDLES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 187 REST OF THE WORLD: NEEDLES MARKET, BY END USER, 2020–2027 (USD MILLION) 162
13 COMPETITIVE LANDSCAPE 163
13.1 OVERVIEW 163
13.2 STRATEGIES ADOPTED BY KEY PLAYERS 163
TABLE 188 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN NEEDLES MARKET 163
13.3 REVENUE SHARE ANALYSIS 164
FIGURE 28 REVENUE ANALYSIS OF KEY PLAYERS IN NEEDLES MARKET 164
13.4 MARKET SHARE ANALYSIS 165
TABLE 189 NEEDLES MARKET: DEGREE OF COMPETITION 165
13.5 COMPANY EVALUATION MATRIX 166
13.5.1 STARS 166
13.5.2 PERVASIVE PLAYERS 166
13.5.3 EMERGING LEADERS 166
13.5.4 PARTICIPANTS 166
FIGURE 29 NEEDLES MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS 167
13.6 COMPANY EVALUATION MATRIX FOR SMES/STARTUPS 167
13.6.1 PROGRESSIVE COMPANIES 167
13.6.2 STARTING BLOCKS 167
13.6.3 RESPONSIVE COMPANIES 168
13.6.4 DYNAMIC COMPANIES 168
FIGURE 30 NEEDLES MARKET: COMPANY EVALUATION MATRIX FOR SMES/STARTUPS 168
13.7 COMPANY FOOTPRINT ANALYSIS 169
13.7.1 REGIONAL FOOTPRINT OF COMPANIES 169
13.7.2 PRODUCT FOOTPRINT OF COMPANIES 170
13.7.3 OVERALL FOOTPRINT OF COMPANIES 171
13.8 COMPETITIVE SCENARIO 172
13.8.1 PRODUCT LAUNCHES 172
TABLE 190 KEY PRODUCT LAUNCHES 172
13.8.2 DEALS 172
TABLE 191 KEY DEALS 172
13.8.3 OTHER DEVELOPMENTS 172
TABLE 192 OTHER KEY DEVELOPMENTS 172
14 COMPANY PROFILES 173
(Business overview, Products offered, Recent developments & MnM View)*
14.1 KEY PLAYERS 173
14.1.1 BECTON, DICKINSON AND COMPANY 173
TABLE 193 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 173
FIGURE 31 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2021) 174
14.1.2 HAMILTON COMPANY 177
TABLE 194 HAMILTON COMPANY: BUSINESS OVERVIEW 177
14.1.3 MEDTRONIC PLC 179
TABLE 195 MEDTRONIC PLC: BUSINESS OVERVIEW 179
FIGURE 32 MEDTRONIC PLC: COMPANY SNAPSHOT (2021) 180
14.1.4 B. BRAUN MELSUNGEN 182
TABLE 196 B. BRAUN MELSUNGEN: BUSINESS OVERVIEW 182
FIGURE 33 B. BRAUN MELSUNGEN: COMPANY SNAPSHOT (2021) 183
14.1.5 STRYKER 185
TABLE 197 STRYKER: BUSINESS OVERVIEW 185
FIGURE 34 STRYKER: COMPANY SNAPSHOT (2021) 186
14.1.6 ETHICON (SUBSIDIARY OF JOHNSON & JOHNSON) 187
TABLE 198 JOHNSON & JOHNSON: BUSINESS OVERVIEW 187
FIGURE 35 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2021) 187
14.1.7 BOSTON SCIENTIFIC CORPORATION 189
TABLE 199 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 189
FIGURE 36 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2021) 190
14.1.8 UNIMED SA 191
TABLE 200 UNIMED SA: BUSINESS OVERVIEW 191
14.1.9 TERUMO CORPORATION 192
TABLE 201 TERUMO CORPORATION: BUSINESS OVERVIEW 192
FIGURE 37 TERUMO CORPORATION: COMPANY SNAPSHOT (2021) 193
14.1.10 OLYMPUS CORPORATION 194
TABLE 202 OLYMPUS CORPORATION: BUSINESS OVERVIEW 194
FIGURE 38 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2021) 195
14.1.11 NIPRO CORPORATION 197
TABLE 203 NIPRO CORPORATION: BUSINESS OVERVIEW 197
FIGURE 39 NIPRO CORPORATION: COMPANY SNAPSHOT (2021) 198
14.1.12 ARGON MEDICAL DEVICES INC. 200
TABLE 204 ARGON MEDICAL DEVICES, INC.: BUSINESS OVERVIEW 200
14.1.13 MERCK KGAA 202
TABLE 205 MERCK KGAA: BUSINESS OVERVIEW 202
FIGURE 40 MERCK KGAA: COMPANY SNAPSHOT (2021) 202
14.1.14 MERIT MEDICAL SYSTEMS 204
TABLE 206 MERIT MEDICAL SYSTEMS: BUSINESS OVERVIEW 204
FIGURE 41 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT (2021) 205
14.1.15 GREINER HOLDING AG 206
TABLE 207 GREINER HOLDING AG: BUSINESS OVERVIEW 206
FIGURE 42 GREINER HOLDING: COMPANY SNAPSHOT (2021) 207
*Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.
14.2 OTHER COMPANIES 208
14.2.1 SMITHS MEDICAL (NOW ICU MEDICAL) 208
14.2.2 ULTIMED, INC. 209
14.2.3 HAKKO CO., LTD. 209
14.2.4 CREGANNA 210
14.2.5 DTR MEDICAL 210
14.2.6 ROCKET MEDICAL PLC 211
15 APPENDIX 212
15.1 DISCUSSION GUIDE 212
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 216
15.3 CUSTOMIZATION OPTIONS 218
15.4 RELATED REPORTS 219
15.5 AUTHOR DETAILS 220

ページTOPに戻る

Table of Contents

Summary

The global Needles Market size is projected to reach USD 10.6 billion by 2027 from USD 7.7 billion in 2022, at a CAGR of 6.7% during the forecast period. Market is driven by factors such as Increasing incidence of accidents, trauma cases and rising number of hospitals in emerging markets. On the other hand, Risk of infections associated with the use of aspiration and biopsy needles is expected to limit market growth to a certain extent in the coming years.

“The Bevel Needles accounted for the largest market share in the Conventional Needle Market, during the forecast period”
The Conventional Needle Market is segmented into Bevel Needles, Blunt Fill Needles, Vented Needles, and Filter Needles. In 2021, Bevel Needles accounted for a sizable market share because most of the market players are focusing on the development of needles with bevel technology for several dental applications.

“Active Needles segment accounted for the largest market share”
Based on type, the safety Needles market is segmented into Active Needles and Passive Needles. The Active Needle segment accounted for the largest market share in 2021 due to their advantages., as these needles provide better penetration through the tissue interface and helps reduce pain and tissue trauma. Moreover, it also reduces tip deflection at deep locations and enhance the visibility of the tip at difficult angles.

“APAC region accounted for the highest CAGR”
The global needles market is divided into four regions: North America, Asia-Pacific, Europe, and Rest of the World. According to the regional analysis, the Asia-Pacific region is likely to retain a significant market share in 2021 and the future. The Asia-Pacific market is being propelled by an increase in geriatric population, increasing healthcare expenditure, a growing number of road accidents. North America, on the other hand, will experience significant growth in the coming years due to increasing incidences of chronic diseases. Increasing prevalence of cardiovascular diseases, increasing surgical procedures.

The primary interviews conducted for this report can be categorized as follows:

• By Company Type: Tier 1 - 32%, Tier 2 - 44%, and Tier 3 - 24%
• By Designation: C-level - 30%, D-level - 34%, and Others - 36%
• By Region: North America - 40%, Europe - 28%, Asia Pacific - 20%, and the Rest of the World – 12%
Lits of Companies Profiled in the Report:
Medtronic (Ireland),
Becton, Dickinson and Company (US),
B. Braun Melsungen AG (Germany),
Stryker Corporation (US),
Ethicon, Inc. (Subsidiary of Johnson and Johnson) (US),
Boston Scientific Corporation (US),
Terumo Corporation (Japan),
Olympus Corporation (US),
Merit Medical (US),
Greiner Holding AG (Austria),
Merck KgA (Germany),
Hamilton Company (US) Unimed SA,
Argon Medical Devices Inc. (US),
Nipro Corporation (Japan),
Smiths Medical (US),
Ultimed Inc. (US),
Hakko Co.Ltd. (Japan),
Creganna (Ireland),
DTR Medical (UK),
Rocket Medical (UK)

Research Coverage:

This report studies the Needles Market based on product, type, delivery mode, material, applications, End user, and region. The report also analyses factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total Needles Market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:

Market Penetration: Comprehensive information on Needles offered by the top 25 players in the market. The report analyses the Needle Market by product, type, delivery mode, material, applications, End user, and region.
Market Development: Comprehensive information about lucrative emerging markets. The report analyses the markets for various securement devices across key geographic regions.
Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the Needle Market
Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the Needle Market
Market Position: It will upkeep stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（金属材料）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（blood）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（金属材料）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（blood）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?